Haberger Vanessa, Elgner Fabian, Roos Jessica, Bender Daniela, Hildt Eberhard
Division of Virology, Paul Ehrlich Institute, Langen, Germany.
Division of Safety of Medical Products and Devices, Paul Ehrlich Institute, Langen, Germany.
Front Cell Dev Biol. 2020 Feb 11;8:44. doi: 10.3389/fcell.2020.00044. eCollection 2020.
After binding of its ligand transferrin, the transferrin receptor (TfR) is internalized via early endosomes. Ligand and receptor can be recycled. α-Taxilin was identified as an essential factor for TfR recycling. Apart from its role for iron uptake, TfR is a coreceptor for hepatitis C virus (HCV) infection. In HCV-replicating cells, the amount of a-taxilin is decreased. This study aims to investigate the effect of decreased α-taxilin levels in HCV-replicating cells on recycling of TfR, its amount on the cell surface, on iron uptake, and the impact of a disturbed TfR recycling on HCV superinfection exclusion. TfR amount and localization were determined by CLSM and surface biotinylation. α-taxilin expression was modulated by CRISPR-Cas9 knockout, siRNA, and stable or transient overexpression. For analysis of HCV superinfection fluorophor-tagged reporter viruses were used. The amount of α-taxilin is decreased in HCV-infected cells. In accordance to this, the protein amount of TfR is significant lower in HCV-positve cells as compared to the control, while TfR expression is not affected. Due to the impaired recycling, internalized TfR is degraded by the endosomal/lysosomal system. The significant lower number of TfR molecules on the cell surface is reflected by reduced transferrin binding/internalization and strong reduction of intracellular iron level. Overexpression of α-taxilin in HCV-replicating cells rescues TfR recycling, augments TfR on the cell surface, and restores transferrin binding. The block of superinfection in HCV-replicating cells could be overcome by overexpression of α-taxilin. Taken together, the diminished level of α-taxilin in HCV-replicating cells prevents recycling of TfR leading to decreased transferrin binding and iron uptake. Disappearance of TfR from the cell surface could be a factor contributing to the exclusion of superinfection by HCV.
转铁蛋白受体(TfR)与其配体转铁蛋白结合后,通过早期内体被内化。配体和受体可以循环利用。α - 微管蛋白结合蛋白被鉴定为TfR循环利用的关键因子。除了其在铁摄取中的作用外,TfR还是丙型肝炎病毒(HCV)感染的共受体。在HCV复制细胞中,α - 微管蛋白结合蛋白的量减少。本研究旨在探讨HCV复制细胞中α - 微管蛋白结合蛋白水平降低对TfR循环利用、其在细胞表面的量、铁摄取的影响,以及TfR循环紊乱对HCV超感染排除的影响。通过共聚焦激光扫描显微镜(CLSM)和表面生物素化测定TfR的量和定位。通过CRISPR - Cas9基因敲除、小干扰RNA(siRNA)以及稳定或瞬时过表达来调节α - 微管蛋白结合蛋白的表达。为了分析HCV超感染,使用了荧光标记的报告病毒。在HCV感染的细胞中,α - 微管蛋白结合蛋白的量减少。据此,与对照组相比,HCV阳性细胞中TfR的蛋白量显著降低,而TfR的表达不受影响。由于循环利用受损,内化的TfR被内体/溶酶体系统降解。细胞表面TfR分子数量的显著减少反映在转铁蛋白结合/内化减少以及细胞内铁水平的大幅降低上。在HCV复制细胞中过表达α - 微管蛋白结合蛋白可挽救TfR的循环利用,增加细胞表面的TfR,并恢复转铁蛋白结合。在HCV复制细胞中,α - 微管蛋白结合蛋白的过表达可以克服超感染的阻断。综上所述,HCV复制细胞中α - 微管蛋白结合蛋白水平的降低阻止了TfR的循环利用,导致转铁蛋白结合和铁摄取减少。TfR从细胞表面消失可能是导致HCV排除超感染的一个因素。